Skip to content

Use of Alginate Carboxymethylcellulose Hyaluronic Acid for Prevention of Intrauterine Adhesion after Vacuum Aspiration in Patients with First Trimester Abortion: A Prospective Randomized controlled trial

Use of Alginate Carboxymethylcellulose Hyaluronic Acid for Prevention of Intrauterine Adhesion after Vacuum Aspiration in Patients with First Trimester Abortion: A Prospective Randomized controlled trial - Use of Alginate Carboxymethylcellulose Hyaluronic Acid for Prevention of Intrauterine Adhesion after Vacuum Aspiration in Patients with First Trimester Abortion: A Prospective Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041898
Enrollment
68
Registered
2020-09-25
Start date
2019-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To examine the effectiveness of intrauterine alginate carboxymethycellulose hyaluronic acid gel application after vacuum aspiration in order to reduce the formation and severity of intrauterine adhesions

Interventions

Intervention: Alginate carboxymethylcellulose hyaluronic acid gel Control: no treatment

Sponsors

Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who were diagnosed of blighted ovum or incomplete abortions or inevitable abortions or embryonic death and underwent termination of pregnancy by manual or electric vacuum aspiration. The inclusion criteria included pregnant patient with gestational age of 13 weeks or less without history of uterine curettage, pelvic infection, clinical evidence of genital tract cancer, intrauterine surgery, IUD used, uterine anomaly, endometriosis, and intolerance or hypersensitivity to ACH gel and its derivatives. All participants agreed to use condom as contraception during the follow up period.

Exclusion criteria

Exclusion criteria: The exclusion criteria included hormonal contraception used, pregnant before the scheduled of hysteroscopy, the complication occurred during or after the procedure such as uterine perforation, infection, incomplete abortion, or need to D&C after the vacuum aspiration. Participants could be terminated by investigators attribute to safety or could voluntarily withdraw from the study for any reason at any time.

Design outcomes

Primary

MeasureTime frame
The primary outcome was the number of women with IUA formation after vacuum aspiration in each group at 8-12 weeks follow-up, comparing between vacuum aspiration alone and vacuum aspiration plus ACH gel application.

Secondary

MeasureTime frame
The secondary outcome was severity of IUA at 8-12 weeks follow-up, comparing between vacuum aspiration alone and vacuum aspiration plus ACH gel application. Also, postoperative complication and adverse events related to the ACH gel application were recorded.

Countries

Asia(except Japan)

Contacts

Public ContactJidapa Vatanatara

Ramathibodi Hospital, Mahidol University Obstetric and Gynaecology

oummy.jidapa.v@gmail.com+66891267037

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026